Skip to content
Advertisement

The Pfizer logo is displayed at the company's headquarters in New York, on Feb. 5, 2021. In a statement on Tuesday, Nov. 16, 2021, drugmaker Pfizer Inc. said it has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental coronavirus pill, in a move that could make its treatment available to more than half of the world’s population. (AP Photo/Mark Lennihan, File)

The Pfizer logo is displayed at the company's headquarters in New York, on Feb. 5, 2021. In a statement on Tuesday, Nov. 16, 2021, drugmaker Pfizer Inc. said it has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental coronavirus pill, in a move that could make its treatment available to more than half of the world’s population. (AP Photo/Mark Lennihan, File)

Featured Photo Galleries